Sign Up to like & get recommendations! 0
Published in 2017 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.26834
Abstract: Edge to edge transcatheter mitral valve repair with MitraClip (Abbott Vascular, Menlo Park, CA) is increasing for high‐risk surgical patients with significant mitral regurgitation. Patients with congenitally corrected transposition of the great arteries (CCTGA) presenting… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.27138
Abstract: The phenomenon of coronary steal is well known in the setting of HLHS (Hypoplastic Left Heart Syndrome) early after the Classical Norwood Operation. We report a rare case of an infant with HLHS [Severe Aortic… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30114
Abstract: Investigate the impact of concomitant tricuspid regurgitation (TR) on clinical outcomes during long‐term follow‐up in patients undergoing percutaneous treatment of mitral regurgitation (MR) with the MitraClip system. read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30221
Abstract: Patients with symptomatic significant mitral regurgitation undergoing mitral transcatheter edge ‐ to ‐ edge repair (TEER) and concomitant tricuspid regurgitation (TR) represent a heteroge-nous population, given they may have underlying left ‐ sided, right ‐… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30307
Abstract: From the first landmark trials of transcatheter edge to edge repair (TEER) in the treatment of mitral regurgitation (MR), it has become abundantly clear that one size (or treatment in this case) does not fit… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30450
Abstract: Severe tricuspid regurgitation (TR) is independently associated with increased morbidity and mortality. Percutaneous transcatheter approaches may offer an alternative for patients not amenable to surgery. read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "ESC Heart Failure"
DOI: 10.1002/ehf2.12491
Abstract: Two recent trials of transcatheter mitral‐valve repair in patients with functional mitral regurgitation (FMR) presented opposing results for the MitraClip® compared to medical therapy alone. The conflicting results gave rise to intensive discussions about assessment… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "ESC Heart Failure"
DOI: 10.1002/ehf2.12577
Abstract: Tricuspid regurgitation in patients with left ventricular assist device (LVAD) has a significant impact on prognosis and quality of life, and its effects on liver and renal function could negatively impact planned heart transplantation. The… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.2159
Abstract: The Italian Society of Interventional Cardiology (GIse) registry Of Transcatheter treatment of mitral valve regurgitaTiOn (GIOTTO) was conceived in order to assess the safety and efficacy of MitraClip therapy in Italy. The aim of this… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.2637
Abstract: To evaluate short‐term changes in tricuspid regurgitation (TR) after transcatheter edge‐to‐edge mitral valve repair (M‐TEER) in secondary mitral regurgitation (SMR), their predictors and impact on mortality. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.2661
Abstract: Right ventricular dysfunction (RVD), as expressed by right ventricular to pulmonary artery coupling, has recently been identified as a strong outcome predictor in patients undergoing mitral valve edge‐to‐edge repair (M‐TEER) for secondary mitral regurgitation (MR).… read more here.